ATE344258T1 - Verfahren zur herstellung von ondansetron und zwischenprodukte dazu - Google Patents
Verfahren zur herstellung von ondansetron und zwischenprodukte dazuInfo
- Publication number
- ATE344258T1 ATE344258T1 AT03718688T AT03718688T ATE344258T1 AT E344258 T1 ATE344258 T1 AT E344258T1 AT 03718688 T AT03718688 T AT 03718688T AT 03718688 T AT03718688 T AT 03718688T AT E344258 T1 ATE344258 T1 AT E344258T1
- Authority
- AT
- Austria
- Prior art keywords
- methyl
- carbazol
- tetrahydro
- formaldehyde
- polar
- Prior art date
Links
- FELGMEQIXOGIFQ-UHFFFAOYSA-N Ondansetron Chemical compound CC1=NC=CN1CC1C(=O)C(C=2C(=CC=CC=2)N2C)=C2CC1 FELGMEQIXOGIFQ-UHFFFAOYSA-N 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 239000013067 intermediate product Substances 0.000 title 1
- 229960005343 ondansetron Drugs 0.000 title 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 abstract 6
- 239000002253 acid Substances 0.000 abstract 3
- 239000003125 aqueous solvent Substances 0.000 abstract 3
- 239000011230 binding agent Substances 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- LXBGSDVWAMZHDD-UHFFFAOYSA-N 2-methyl-1h-imidazole Chemical compound CC1=NC=CN1 LXBGSDVWAMZHDD-UHFFFAOYSA-N 0.000 abstract 2
- HHJUJCWZKJMCLC-UHFFFAOYSA-N 9-methyl-2,3-dihydro-1h-carbazol-4-one Chemical compound C12=CC=CC=C2N(C)C2=C1C(=O)CCC2 HHJUJCWZKJMCLC-UHFFFAOYSA-N 0.000 abstract 2
- 239000002243 precursor Substances 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- -1 by contacting (II) Substances 0.000 abstract 1
- AMLYRCOEFHJSFS-UHFFFAOYSA-N carbazol-1-one Chemical compound C1=CC=C2C3=CC=CC(=O)C3=NC2=C1 AMLYRCOEFHJSFS-UHFFFAOYSA-N 0.000 abstract 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 abstract 1
- 239000011541 reaction mixture Substances 0.000 abstract 1
- 150000003335 secondary amines Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Impact Printers (AREA)
- Machines For Manufacturing Corrugated Board In Mechanical Paper-Making Processes (AREA)
- Optical Couplings Of Light Guides (AREA)
- Pressure Welding/Diffusion-Bonding (AREA)
- Footwear And Its Accessory, Manufacturing Method And Apparatuses (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
- Forging (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44205503P | 2003-01-24 | 2003-01-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE344258T1 true ATE344258T1 (de) | 2006-11-15 |
Family
ID=23755350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03718688T ATE344258T1 (de) | 2003-01-24 | 2003-03-14 | Verfahren zur herstellung von ondansetron und zwischenprodukte dazu |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7041834B2 (de) |
| EP (1) | EP1585744B1 (de) |
| AT (1) | ATE344258T1 (de) |
| AU (2) | AU2003222763A1 (de) |
| DE (1) | DE60309511T2 (de) |
| FR (1) | FR2850381B1 (de) |
| GB (1) | GB2398071B (de) |
| NL (1) | NL1022894C2 (de) |
| NO (1) | NO20053928L (de) |
| WO (1) | WO2004065381A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100566317B1 (ko) * | 2003-10-16 | 2006-03-30 | 주식회사유한양행 | 카바졸온 유도체 제조 방법 |
| US7696356B2 (en) * | 2004-08-17 | 2010-04-13 | Taro Pharmaceutical Industries Limited | Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one and ondansetron therefrom |
| WO2006046253A1 (en) * | 2004-10-26 | 2006-05-04 | Ipca Laboratories Limited | A one-pot process for the preparation of antiemetic agent, 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl)-1h-imidazole-1-yl)methyl]-4h-carbazol-4-o |
| US20110118189A1 (en) * | 2008-04-28 | 2011-05-19 | Farr Stephen J | Novel formulations for treatment of migraine |
| CN109020871A (zh) * | 2018-10-03 | 2018-12-18 | 淮安安莱生物科技有限公司 | 一种昂丹司琼杂质a的制备方法 |
| CN115677561B (zh) * | 2022-11-01 | 2024-04-05 | 常州兰陵制药有限公司 | 一种1,2,3,4-四氢-9-甲基-4h-咔唑酮及其合成方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4695578A (en) * | 1984-01-25 | 1987-09-22 | Glaxo Group Limited | 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances |
| PH22672A (en) * | 1984-01-25 | 1988-11-14 | Glaxo Group Ltd | Imidazolylmethyltetrahydrocarbazolone derivatives, composition and method of use thereof |
| CN1107474A (zh) | 1994-03-31 | 1995-08-30 | 北京四达生物技术研究所 | 一种四氢咔唑酮衍生物的制备方法 |
| CN1040644C (zh) | 1994-04-29 | 1998-11-11 | 北京天衡时代科技集团 | 一种4-氢咔唑酮衍生物的制备方法 |
| CN1035672C (zh) * | 1994-08-08 | 1997-08-20 | 上海医科大学 | 3－(甲基咪唑基)－甲基－四氢－咔唑酮新的制备方法 |
| EP1085888A1 (de) * | 1998-06-08 | 2001-03-28 | Advanced Medicine, Inc. | Multivalente agonisten, partielle antagonisten, inverse agonisten und antagonisten des 5-ht 3-rezeptors |
| ES2219201T1 (es) * | 2001-01-11 | 2004-12-01 | Teva Pharmaceutical Industries Ltd. | Procedimiento mejorado para la preparacion de ondansetron clorhidrato dihidrato puro. |
-
2003
- 2003-03-04 GB GB0304924A patent/GB2398071B/en not_active Expired - Fee Related
- 2003-03-11 NL NL1022894A patent/NL1022894C2/nl not_active IP Right Cessation
- 2003-03-14 AU AU2003222763A patent/AU2003222763A1/en not_active Abandoned
- 2003-03-14 AT AT03718688T patent/ATE344258T1/de not_active IP Right Cessation
- 2003-03-14 DE DE60309511T patent/DE60309511T2/de not_active Expired - Fee Related
- 2003-03-14 EP EP03718688A patent/EP1585744B1/de not_active Expired - Lifetime
- 2003-03-14 WO PCT/EP2003/002743 patent/WO2004065381A1/en not_active Ceased
- 2003-04-03 FR FR0304140A patent/FR2850381B1/fr not_active Expired - Fee Related
- 2003-04-08 AU AU2003203585A patent/AU2003203585A1/en not_active Abandoned
-
2004
- 2004-01-23 US US10/762,552 patent/US7041834B2/en not_active Expired - Fee Related
-
2005
- 2005-08-23 NO NO20053928A patent/NO20053928L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2850381A1 (fr) | 2004-07-30 |
| FR2850381B1 (fr) | 2006-06-09 |
| NL1022894C2 (nl) | 2004-07-28 |
| GB2398071B (en) | 2006-06-07 |
| NO20053928D0 (no) | 2005-08-23 |
| AU2003203585A1 (en) | 2004-08-12 |
| EP1585744A1 (de) | 2005-10-19 |
| US7041834B2 (en) | 2006-05-09 |
| AU2003222763A1 (en) | 2004-08-13 |
| US20040181076A1 (en) | 2004-09-16 |
| DE60309511T2 (de) | 2007-06-28 |
| GB2398071A (en) | 2004-08-11 |
| NO20053928L (no) | 2005-10-24 |
| EP1585744B1 (de) | 2006-11-02 |
| GB0304924D0 (en) | 2003-04-09 |
| DE60309511D1 (de) | 2006-12-14 |
| WO2004065381A1 (en) | 2004-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200700545A1 (ru) | Производные изоксазолина и их применение в качестве гербицидов | |
| WO2008010897A3 (en) | Process for making 3-substituted 2-amino-5-halobenzamides | |
| ATE371657T1 (de) | Verfahren zur herstellung kondensierter oxazinone aus einer aromatischen ortho-aminocarbonsäure und einer carbonsäure in gegenwart eines sulfonylchlorids und pyridin | |
| EP1477481A4 (de) | Verfahren zur herstellung eines chinazolin-4-onderivats | |
| ATE442363T1 (de) | Verfahren zur herstellung von pyridinverbindungen | |
| DE59810363D1 (de) | Verfahren zur herstellung von triazolinthion-derivaten | |
| ATE422200T1 (de) | Verfahren zur herstellung substituierter nikotinsäureester | |
| MXPA03005429A (es) | Procedimiento para preparacion de imidazotriazinonas sustituidas con sulfonamida. | |
| EA200701470A1 (ru) | Способы получения производных 4-(фенокси-5-метилпиримидин-4-илокси)пиперидин-1-карбоновой кислоты и родственных соединений | |
| DE60309511D1 (de) | Verfahren zur herstellung von ondansetron und zwischenprodukte dazu | |
| TW200500340A (en) | Processes for producing cyclic benzamidine derivative | |
| ATE419230T1 (de) | Verfahren zur herstellung von 2,6-dihalo-para- trifluoromethylanilin | |
| ATE240286T1 (de) | Verfahren zur herstellung von 1-aryl-3- cyclopropyl-1,3-propandionen | |
| ATE244706T1 (de) | Enantiomere von mercaptolactonen und verfahren zu ihrer herstellung | |
| ATE312082T1 (de) | Verfahren zur herstellung von dicyanomethyliden und heterozyklische verbindungen | |
| ATE364611T1 (de) | Verfahren zur herstellung von 1,2,3,9-tetrahydro- 9-methyl-3- (2-methyl-1h-imidazol-1-yl)methylö- h-carbazol-4-on | |
| ATE425959T1 (de) | Verfahren zur herstellung von amino- oder hydroxybenzonitrilen | |
| ATE264857T1 (de) | Verfahren zur herstellung von heterocyclischen verbindungen | |
| MXPA05008179A (es) | Procedimiento para la fabricacion de alcaloides de quinazolina. | |
| DE59809027D1 (de) | Verfahren zur herstellung von alkoxytriazolinonen | |
| ATE417814T1 (de) | Verfahren zur herstellung von tetracarbonsäuren | |
| HRP20000279B1 (en) | Process for the preparation of sildenaphyl and intermediates | |
| DE60317519D1 (de) | Verfahren zur herstellung von tetrahydropyran-4-ol, zwischenprodukte daf r und verfahren zu dessen herstellung | |
| JPS6061575A (ja) | 複素環式化合物の製法 | |
| ATE365716T1 (de) | Verfahren zur herstellung von diiminverbindungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |